|
| 36868206 | Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. | Am J Hum Genet | 2023 |
| 37723522 | The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study. | Genome Med | 2023 |
| 36650482 | Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort. | BMC Cancer | 2023 |
| 36868206 | Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcare. | Am J Hum Genet | 2023 |
| 36933623 | Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer. | Gastroenterology | 2023 |
| 37723522 | The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants-a multi-site prospective cohort study. | Genome Med | 2023 |
| 36650482 | Colon and rectal cancer treatment patterns and their associations with clinical, sociodemographic and lifestyle characteristics: analysis of the Australian 45 and Up Study cohort. | BMC Cancer | 2023 |
| 36933623 | Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer. | Gastroenterology | 2023 |
| 35151314 | The complexities, coordination, culture and capacities that characterise the delivery of oncology services in the common areas of ambulatory settings. | BMC Health Serv Res | 2022 |
| 35398189 | Antibiotic exposure within six months before systemic therapy was associated with lower cancer survival. | J Clin Epidemiol | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 35809086 | The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. | Genet Med | 2022 |
| 35151314 | The complexities, coordination, culture and capacities that characterise the delivery of oncology services in the common areas of ambulatory settings. | BMC Health Serv Res | 2022 |
| 35809086 | The predicted effect and cost-effectiveness of tailoring colonoscopic surveillance according to mismatch repair gene in patients with Lynch syndrome. | Genet Med | 2022 |
| 35398189 | Antibiotic exposure within six months before systemic therapy was associated with lower cancer survival. | J Clin Epidemiol | 2022 |
| 36222710 | Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. | Clin Cancer Res | 2022 |
| 33349137 | Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer. | Med Decis Making | 2021 |
| 33941174 | Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop. | BMC Health Serv Res | 2021 |
| 33836815 | Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice. | Hered Cancer Clin Pract | 2021 |
| 33349137 | Extrapolation of Survival Curves Using Standard Parametric Models and Flexible Parametric Spline Models: Comparisons in Large Registry Cohorts with Advanced Cancer. | Med Decis Making | 2021 |
| 33168572 | Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility. | J Med Genet | 2021 |
| 34408148 | Queensland Genomics: an adaptive approach for integrating genomics into a public healthcare system. | NPJ Genom Med | 2021 |
| 34372907 | Providing outpatient cancer care for CALD patients: a qualitative study. | BMC Res Notes | 2021 |
| 33836815 | Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice. | Hered Cancer Clin Pract | 2021 |
| 34408148 | Queensland Genomics: an adaptive approach for integrating genomics into a public healthcare system. | NPJ Genom Med | 2021 |
| 33941174 | Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop. | BMC Health Serv Res | 2021 |
| 34372907 | Providing outpatient cancer care for CALD patients: a qualitative study. | BMC Res Notes | 2021 |
| 33168572 | Implementing gene curation for hereditary cancer susceptibility in Australia: achieving consensus on genes with clinical utility. | J Med Genet | 2021 |
| 31595523 | The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. | Med J Aust | 2020 |
| 32321474 | Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial. | BMC Cancer | 2020 |
| 31595523 | The predicted impact and cost-effectiveness of systematic testing of people with incident colorectal cancer for Lynch syndrome. | Med J Aust | 2020 |
| 32191753 | Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP). | PLoS One | 2020 |
| 32047231 | Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation. | Mod Pathol | 2020 |
| 32041593 | What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence. | BMC Health Serv Res | 2020 |
| 32565470 | Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia. | BMJ Open | 2020 |
| 32998968 | Global approaches to genomic medicine implementation. | Sci Transl Med | 2020 |
| 32047231 | Tumour infiltrating lymphocyte status is superior to histological grade, DNA mismatch repair and BRAF mutation for prognosis of colorectal adenocarcinomas with mucinous differentiation. | Mod Pathol | 2020 |
| 32041593 | What are the attitudes of health professionals regarding patient reported outcome measures (PROMs) in oncology practice? A mixed-method synthesis of the qualitative evidence. | BMC Health Serv Res | 2020 |
| 32998968 | Global approaches to genomic medicine implementation. | Sci Transl Med | 2020 |
| 32321474 | Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial. | BMC Cancer | 2020 |
| 32565470 | Pathways to a cancer-free future: a protocol for modelled evaluations to minimise the future burden of colorectal cancer in Australia. | BMJ Open | 2020 |
| 32191753 | Diagnostic and health service pathways to diagnosis of cancer-registry notified cancer of unknown primary site (CUP). | PLoS One | 2020 |
| 29382774 | Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes. | Gut | 2019 |
| 31601594 | What is multidisciplinary cancer care like in practice? a protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector. | BMJ Open | 2019 |
| 30620048 | Evaluation of the transferability of survival calculators for stage II/III colon cancer across healthcare systems. | Int J Cancer | 2019 |
| 29382774 | Lymphocytic response to tumour and deficient DNA mismatch repair identify subtypes of stage II/III colorectal cancer associated with patient outcomes. | Gut | 2019 |
| 30668711 | Association of ten gastrointestinal and other medical conditions with positivity to faecal occult blood testing in routine screening: a large prospective study of women in England. | Int J Epidemiol | 2019 |
| 31360895 | Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing. | JNCI Cancer Spectr | 2019 |
| 31601594 | What is multidisciplinary cancer care like in practice? a protocol for a mixed-method study to characterise ambulatory oncology services in the Australian public sector. | BMJ Open | 2019 |
| 31360895 | Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing. | JNCI Cancer Spectr | 2019 |